Press Room

2025 AIChE Annual meeting

Start
Sunday, November 02, 2025 - 17:37
End
Thursday, November 06, 2025 - 17:38
Location: Boston, United States

Meet Hovione team at the 2025 AIChE Annual Meeting and find their exciting presentations and Hovione’s latest research and innovations. The AIChE Annual Meeting is an educational forum covering a wide range of topics relevant to cutting-edge research, new technologies, and emerging growth areas in chemical engineering. We look forward to meeting academic and industry experts and exchanging knowledge.

Date: November 2

Oral communication

Title: Early Development of a Modified Release Formulation and Process for Continuous Direct Compression: A Case Study (NH10 case study) 

Presenting Author: Ricardo Sousa, Senior Scientist

3:48 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Continuous Dosing and Blending (CDB) As a Laboratory Tool to Expedite Process Development

Presenting Author: Ana Costa, Senior Scientist

4:06 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Exploring Synergies between SMEs and AI-Powered Tools in Reaction Optimization

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:45 PM - Room 309 (Third Level, Hynes Convention Center)



Date: November 3

Poster

Title: GMP Flow Chemistry Platforms: A CDMO Perspective on Enabling the Next Generation of Clinical-Stage API Manufacturing

Presenting Author: Rudi Oliveira, Senior Scientist

3:30 PM - Room Exhibit Hall C (Second Level, Hynes Convention Center)

Oral communication

Title: From offline to inline: Advancing inhalation drug manufacturing with real-time particle size monitoring and solids concentration modelling

Presenting Author: Nichal Gentilal, Scientist

8:54 AM - Room 313 (Hynes Convention Center)

 

Date: November 4

Oral communication

Title: Scaling Down Fluid Bed Drying: A Comparative Study of Mini-Glatt and Consigma™-1

Presenting Author: Ricardo Sousa, Senior Scientist

4:42 PM - Room Liberty Ballroom B (2, Sheraton Boston)

Oral communication

Title: Process development & control strategies with PAT and Soft-sensors: A solvent swap case-study

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:42 PM - Room 309 (Third Level, Hynes Convention Center)

Oral communication

Title: Exploring Novel Excipients in the Transition from Batch to Continuous Tableting (CT)

Presenting Author: Ana Costa, Senior Scientist

4:54 PM - Room 308 (Third Level, Hynes Convention Center)

Oral communication

Title: Safety By Design: Leveraging Data-Rich Experimentation and Process Modeling Towards a Digital Twin

Presenting Author: Rudi Oliveira, Senior Scientist

5:00 PM - Room 309 (Hynes Convention Center)

 

Hovione Team Members will also chair the following sessions:

Nov. 2

Title: Continuous Processing in Drug Product

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification  

3:30 PM – Room 308 (Hynes Convention Center)

Nov. 3

Title: Particle Characterization            

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification 

8:00 AM - Room Independence Ballroom West

Nov. 3

Title: Advances in Smart Monitoring, Optimization and Control of Process Manufacturing

Presenting Author: Ankita Naik, Modeling and PAT Scientist

8:00 AM - Room 304 (Hynes Convention Center)

 

Contact our experts today to find out more about the work we are doing to support our customers’ projects, solving complex challenges, and bringing needed therapies to life.

Let’s discuss your project together.

schedule a meeting

 

 

 

 

 

Also in the Press Room

See All

The CDMO’s New Jersey manufacturing site expansion will eventually cover more than 200,000 square feet. Portugal-based contract development and manufacturing organisation (CDMO) Hovione has completed an initial $100 million investment round in its East Windsor, New Jersey site. Once completed it will increase the facility’s footprint to more than 200,000 square feet and more than double its capacity for spray drying. Hovione CEO Jean-Luc Herbeaux said: “Since launching our New Jersey operations in 2002, Hovione has been one of the longest established European CDMOs in the United States. “This investment reinforces Hovione’s leadership in spray drying – a core technology platform where we have built extensive know-how and capabilities. By continuing to advance our platforms and expand capacity in the US, we are strengthening the foundation that enables our partners to bring complex medicines to patients more efficiently.” Spray drying is an increasingly important particle engineering technology for improving drug bioavailability through the amorphous solid dispersion (ASD) that can address bioavailability or crystallisation challenges. The initial phase of Hovione’s expansion will include a 31,000-square-foot building to house two size-3 spray dryers (PSD-3) designed for ASD production. Construction at the New Jersey site is already underway and the company plans to start GMP operations in the second quarter of 2026. The initiative is part of Hovione’s long-term strategy to grow its US operations and enhance its integrated drug substance, drug product intermediate and drug product capabilities. Herbeaux said: “This investment addresses growing customer demand for US-based capacity and integrated solutions that shorten development timelines and reduce tech transfer complexity. By consolidating development, scale-up, and commercial manufacturing within a single quality and governance framework, we provide customers with seamless execution from drug substance to drug product.” The company’s New Jersey expansion fits into its wider international growth plan that also includes capacity investments in Ireland and Portugal as it seeks to create a network of autonomous sites spanning the development and commercialisation of APIs, drug product intermediates and drug products.   Read the full article at EuropeanPharmaceuticalReview.com  

Press Clipping

Hovione doubles spray drying capacity with $100m US investment round

Nov 04, 2025

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Lonza, SK pharmteco/Lotte Biologics, Hovione, Sai Life Sciences, BioCina, Alcami, Piramal Pharma/IntoCell and Roquette. Formulation Development/Drug Product Manufacturing: Hovione Completes Initial $100-M Investment Cycle in US Operations Hovione, a CDMO of drug substances and drug products, has completed an initial $100-million investment cycle at its site in East Windsor, New Jersey, as part of a strategy to increase its US operations and enhance its integrated drug-substance, drug-product intermediate, and drug-product capabilities. Upon completion, the site will cover more than 200,000 square feet.   The initial expansion phase includes a 31,000-square-foot building that will house two size-3 spray dryers (PSD-3) designed for production of amorphous solid dispersions (ASDs). This investment more than doubles Hovione’s spray-drying capacity in the US by expanding capabilities for ASD development and commercial manufacturing. Construction is underway at the New Jersey site, with GMP operations planned to start in the second quarter of 2026.  As part of this expansion, Hovione has also acquired additional adjacent land to enable future growth at the East Windsor site. The 125,000-square-foot greenfield will support large-scale production, including continuous and batch tableting capacity, and introduce the latest pharmaceutical technologies and digital innovation with enhanced quality control and R&D capabilities.    Read the full article at DCATvci.org  

Press Clipping

Supplier News: Thermo Fisher, Lonza, SK pharmteco, Hovione & More

Oct 30, 2025